Literature DB >> 10918366

Electrospray tandem mass spectrometry in the rapid identification of alpha-chain haemoglobin variants.

D K Rai1, G Alvelius, B Landin, W J Griffiths.   

Abstract

The potential use of electrospray tandem mass spectrometry in the rapid characterisation of haemoglobin variants found in the Swedish population has been assessed. Analysis times of the order of 5 -10 min were routinely achieved, and identification of variants using mass spectrometry as the sole analytical technique was possible. However, additional information, readily available from isoelectric focusing experiments, made identification simpler and more secure. In the present communication we report on the identification of the alpha-chain variants, Hb Russ, Hb Le Lamentin and Hb Q-Iran. The identifications were confirmed by the use of nucleotide sequencing techniques. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918366     DOI: 10.1002/1097-0231(20000730)14:14<1184::AID-RCM7>3.0.CO;2-S

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  3 in total

1.  Characterization of the elusive disulfide bridge forming human Hb variant: Hb Ta-Li beta83 (EF7)Gly --> Cys by electrospray mass spectrometry.

Authors:  Dilip K Rai; Britta Landin; William J Griffiths; Gunvor Alvelius; Brian N Green
Journal:  J Am Soc Mass Spectrom       Date:  2002-02       Impact factor: 3.109

2.  Ion trap collision-induced dissociation of human hemoglobin alpha-chain cations.

Authors:  Tegafaw T Mekecha; Ravi Amunugama; Scott A McLuckey
Journal:  J Am Soc Mass Spectrom       Date:  2006-05-15       Impact factor: 3.109

3.  Haemoglobin Södertälje (beta118 Phe-->Val): a new mutation in human haemoglobin identified by electrospray ionisation mass spectrometry.

Authors:  Dilip K Rai; Britta Landin; Gunvor Alvelius; William J Griffiths
Journal:  Rapid Commun Mass Spectrom       Date:  2006       Impact factor: 2.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.